Senior Principal Scientist, In Vivo Pharmacology - MASH & Liver Fibrosis

Obesity Comorbidities Pharmacology  

Måløv, Denmark 

Are you ready to shape the future of therapies for obesity-related liver disease and redefine treatment possibilities for patients living with metabolic dysfunction-associated steatohepatitis (MASH)? 

We are seeking a Senior Principal Scientist with deep expertise in MASH, liver fibrosis, inflammation, and translational pharmacology to drive scientific innovation and advance transformative therapies within obesity and cardiometabolic diseases. In this role, you will help unlock the next generation of medicines targeting obesity-related liver disease, addressing a major unmet medical need and improving the lives of millions of patients worldwide. 

Your new role 

As Senior Principal Scientist, you will serve as the in vivo pharmacology subject matter expert in MASH and liver fibrosis biology. You will provide scientific leadership and guidance across drug discovery programs, shaping...